Services Mapping Among Older Adults With Hip Fracture

Hip Fractures Clinical Trial

— HiFit  

Official title:

Multicenter Prospective Observational Study in Hip Fracture Among Older Adults

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03184896
• Other study ID #: 0281001
• Status: Active, not recruiting
• Start date: November 14, 2018
• Est. completion date: November 13, 2021

Study information

• Verified date: February 2020
• Source: The George Institute for Global Health, China
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Hip fracture is a osteoporosis-related fracture with higher mortality, and is a major public health issue in China. The British Orthopedic Association and the British Geriatric Society have published the UK Blue Book, which summarizes current evidence and best practice in the hip fracture care and secondary prevention, but this kind of standardized practice in hip fracture care is not yet existed in China. The Blue Book standards will be used as the most contemporary evidence-based guidelines for management of hip fracture.This study is to prospectively examine the barriers and facilitators in the current management of hospital in China by comparing the Blue Book standards.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 2500
• Est. completion date: November 13, 2021
• Est. primary completion date: November 13, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Adults aged 65 years old or over;

• Hip fracture with X-ray-confirmed femoral neck, trochanteric or sub-trochanteric fracture;

• Within 21 days of a hip fracture;

• Willingness to sign informed consent form;

Exclusion Criteria:

• Patients with pathological fractures;

• With terminal malignancies.

Related Conditions & MeSH terms

• Fractures, Bone
• Hip Fractures

Intervention

Procedure:
• Hip Fracture Surgery
Hip Fracture Surgery

Locations

Country	Name	City	State
China	The George Institute	Beijing

Sponsors (8)

Lead Sponsor	Collaborator
The George Institute for Global Health, China	Beijing Anzhen Hospital, Beijing Changping District Hospital, Beijing Fangshan District Liangxiang Hospital, Beijing Friendship Hospital, Beijing Hospital, Beijing Jishuitan Hospital, Beijing Shuyi Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Mortality Rate in One Month, Four-Month, and One Year	The mortality rate in one, four-month, and one year after admission to hospital	One month, four-month, and one year
Other	The Incidence of Complications in One Month, Four-Month, and One year	The incidence of complications in one month, four-month and one year after admission to hospital, including pneumonia, deep vein thrombosis, heart disease, etc.	One month, four-month, and one year
Primary	Operative administration within 48 hours	The proportion of patients who are operated within 48 hours in the past one year	One year
Secondary	A&E Admission within 4 hours	The proportion of patients who admit to orthopaedic ward from A&E within 4 hours in the past one year	One year
Secondary	The Incidence of Pressure Ulcer	The incidence of pressure ulcer in the past one year via nurses provide assessment	One year
Secondary	The Proportion of Patients Who Receive Geriatrician Assessment	The proportion of patients who receive the assessment of geriatricians in the past one year	One year
Secondary	The Proportion of Patients Who Receive Osteoporosis Assessment and Treatment	The proportion of patients who receive osteoporosis assessment and treatment the hospital provided in the past one year	One year
Secondary	The Proportion of Patients Who Receive Specialist Falls Assessment	The proportion of patients who receive specialist falls assessment in the past one year	One year